0001209191-18-057721.txt : 20181108 0001209191-18-057721.hdr.sgml : 20181108 20181108141806 ACCESSION NUMBER: 0001209191-18-057721 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181106 FILED AS OF DATE: 20181108 DATE AS OF CHANGE: 20181108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Szela Mary T CENTRAL INDEX KEY: 0001410289 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37620 FILM NUMBER: 181169254 MAIL ADDRESS: STREET 1: 10835 ROAD TO THE CURE STREET 2: SUITE 205 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kura Oncology, Inc. CENTRAL INDEX KEY: 0001422143 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 611547851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3033 SCIENCE PARK ROAD, SUITE 220 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 500-8800 MAIL ADDRESS: STREET 1: 3033 SCIENCE PARK ROAD, SUITE 220 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: ZETA ACQUISITION CORP III DATE OF NAME CHANGE: 20071227 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-11-06 0 0001422143 Kura Oncology, Inc. KURA 0001410289 Szela Mary T C/O KURA ONCOLOGY, INC. 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121 1 0 0 0 Option to purchase common stock 11.55 2018-11-06 4 A 0 30000 0.00 A 2028-11-05 Common Stock 30000 30000 D Option to purchase common stock 11.55 2018-11-06 4 A 0 7583 0.00 A 2028-11-05 Common Stock 7583 7583 D This option vests in three equal annual installments commencing on the one year anniversary of the date of grant. This option vests in full on the one year anniversary of the date of grant. Annette North, Attorney-in-fact for Mary Szela 2018-11-08